米国企業
RECURSION PHARMACEUTICALS, INC.

RECURSION PHARMACEUTICALS, INC.RXRX

時価総額

$16.3億

PER

	2021年 12月31日	2022年 12月31日	2023年 12月31日
Cash and cash equivalents	285	550	392
Restricted cash	2	1	3
Accounts receivable	0	-	-
Other receivables	9	3	3
Other receivables	9	3	3
Other current assets	8	16	40
Investments	231	-	-
Total current assets	535	570	438
Other current assets	8	16	40
Total current assets	535	570	438
Restricted Cash, Noncurrent	9	8	7
Property and equipment, net	65	88	87
Operating lease right-of-use assets	-	33	34
Intangible assets, net	1	1	36
Goodwill	1	1	52
Other Assets, Noncurrent	0	-	0
Total assets	610	701	654
Accounts payable	3	5	4
Accrued Liabilities, Current	32	33	47
Unearned revenue	10	57	36
Notes payable	0	0	0
Operating lease liabilities	-	6	6
Total current liabilities	47	100	93
Total current liabilities	47	100	93
Deferred rent	4	-	-
Unearned revenue, non-current	7	70	51
Unearned revenue, non-current	7	70	51
Notes Payable, Noncurrent	1	1	1
Notes Payable, Noncurrent	1	1	1
Operating Lease, Liability, Noncurrent	-	44	43
Operating Lease, Liability, Noncurrent	-	44	43
Deferred tax liabilities	-	-	1
Lease Incentive, Payable, Noncurrent	9	-	-
Total liabilities	67	215	190
Total liabilities	67	215	190
Common Stock, Value, Issued	0	0	0
Additional paid-in capital	943	1,125	1,431
Accumulated deficit	-400	-640	-968
Accumulated other comprehensive loss	-0	-	-
Total stockholders’ equity	543	486	463
Total stockholders’ equity	543	486	463
Common Stock, Value, Issued	0	0	0
Additional paid-in capital	943	1,125	1,431
Accumulated deficit	-400	-640	-968
Accumulated other comprehensive loss	-0	-	-
Total stockholders’ equity	543	486	463
Total stockholders’ equity	543	486	463
Total liabilities and stockholders’ equity	610	701	654
Total liabilities and stockholders’ equity	610	701	654